explore -WSS

explore

author：comprehensive 2025-09-29 22:50:14 - browse：5

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Judge denies Trump's request for new trial in E. Jean Carroll case

entertainment

WSS

'Essentially witchcraft:' A former naturopath takes on the field

How a Boston hospital is priming medical residents to use GPT

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Are infertility treatments 'essential' during the Covid

Stephen Quake on the Chan Zuckerberg quest to conquer disease

New report analyzes digital physical therapy solutions' effectiveness

focus

explore

explore

Peter Hotez and the public health issue of online harassment

After a decade, new Gardasil ad campaign gets it (mostly) right

Novavax promises a turnaround & Lilly roils the obesity market

Dementia risk linked to living in disadvantaged areas: Study

How to save PrEP access — and even expand it

Moderna says combo Covid

Continuity nursing helped my family in our darkest PICU moments

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Duchenne breakthrough therapy leaves behind pioneering families

US jobless claims fall again as labor market continues to flash strength

explore

California wildfire smoke linked to 52,000 early deaths, study says

Extensive review finds private equity owners jack up cost of care

A new ‘biological computer' targets cancer while sparing healthy cells

5 dead in mass shooting on Caribbean island of St. Vincent: Police

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

In rare move, senator releases unverified FBI source report alleging Biden bribe

entertainment

entertainment

leisure time

hotspot